Literature DB >> 29794706

External Port Tissue Expansion in the Pediatric Population: Confirming Its Safety and Efficacy.

Beina Azadgoli1,2, Artur Fahradyan1,2, Erik M Wolfswinkel1,2, Michaela Tsuha1,2, William Magee1,2, Jeffrey A Hammoudeh1,2, Mark M Urata1,2, Lori K Howell1,2.   

Abstract

BACKGROUND: External filling ports in tissue expander-based reconstruction have the advantages of being associated with less pain and emotional distress. However, among practicing surgeons using tissue expansion, a theoretical concern remains regarding higher risk of infection. The authors' goal was to evaluate external port safety in the pediatric population by looking at the complications and overall success rate of reconstruction.
METHODS: A retrospective review of all patients undergoing tissue expansion using external ports at Children's Hospital Los Angeles between January of 2008 and June of 2016 was conducted. Patient demographic and perioperative data were collected and analyzed.
RESULTS: Two hundred forty-one expanders were placed in 100 pediatric patients, resulting in 123 procedures for congenital and acquired conditions, with an average age at the time of surgery of 7.1 years (range, 1 month to 19.9 years) and average follow-up length of 2.5 years (range, 2.8 months to 8.8 years). The overall complication rate was 29.9 percent, and the infection rate was 17 percent. The majority of these cases were treated conservatively without additional need for surgery. Of 123 cases, 25 required premature expander removal because of complications. Despite early intervention, 21 of these cases underwent successful completion of their reconstruction according to the preoperative plan, resulting in an overall 96.7 percent success rate of tissue expander reconstruction.
CONCLUSIONS: In children, who are often less tolerant of the pain and distress associated with internal port expansion, the authors encourage the use of external ports. This study found a high success rate in terms of successful reconstruction, with the majority of complications being treated conservatively. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, IV.

Entities:  

Mesh:

Year:  2018        PMID: 29794706     DOI: 10.1097/PRS.0000000000004372

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  5 in total

1.  Surgical Antimicrobial Prophylaxis in Pediatric Patients Undergoing Plastic Surgery: A RAND/UCLA Appropriateness Method Consensus Study.

Authors:  Susanna Esposito; Rossella Sgarzani; Sonia Bianchini; Sara Monaco; Laura Nicoletti; Erika Rigotti; Marilia Di Pietro; Roberta Opri; Caterina Caminiti; Matilde Ciccia; Giorgio Conti; Daniele Donà; Mario Giuffré; Stefania La Grutta; Laura Lancella; Mario Lima; Andrea Lo Vecchio; Gloria Pelizzo; Giorgio Piacentini; Carlo Pietrasanta; Matteo Puntoni; Alessandro Simonini; Elisabetta Venturini; Annamaria Staiano; Nicola Principi
Journal:  Antibiotics (Basel)       Date:  2022-04-11

Review 2.  Multidisciplinary Application of an External Tissue Expander Device to Improve Patient Outcomes: A Critical Review.

Authors:  Brendan J MacKay; Anthony N Dardano; Andrew M Klapper; Selene G Parekh; Mohsin Q Soliman; Ian L Valerio
Journal:  Adv Wound Care (New Rochelle)       Date:  2020-02-19       Impact factor: 4.730

3.  Risk factors for tissue expander infection in scar reconstruction: a retrospective cohort study of 2374 consecutive cases.

Authors:  Chen Dong; Minhui Zhu; Luguang Huang; Wei Liu; Hengxin Liu; Kun Jiang; Zhou Yu; Xianjie Ma
Journal:  Burns Trauma       Date:  2021-01-04

4.  Macrophages are necessary for skin regeneration during tissue expansion.

Authors:  Jianke Ding; Lei Lei; Shiqiang Liu; Yu Zhang; Zhou Yu; Yingjun Su; Xianjie Ma
Journal:  J Transl Med       Date:  2019-01-21       Impact factor: 5.531

Review 5.  Tissue expansion reconstruction of head and neck burn injuries in paediatric patients - A systematic review.

Authors:  Martha F I De La Cruz Monroy; Deepak M Kalaskar; Khawaja Gulraiz Rauf
Journal:  JPRAS Open       Date:  2018-10-26
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.